NASDAQ:MLAB Mesa Laboratories (MLAB) Stock Price, News & Analysis $74.15 +3.41 (+4.82%) Closing price 04:00 PM EasternExtended Trading$74.08 -0.07 (-0.09%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Mesa Laboratories Stock (NASDAQ:MLAB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Mesa Laboratories alerts:Sign Up Key Stats Today's Range$70.59▼$75.0050-Day Range$59.53▼$74.1552-Week Range$55.45▼$155.12Volume90,386 shsAverage Volume179,786 shsMarket Capitalization$407.83 millionP/E Ratio9.89Dividend Yield0.86%Price Target$67.00Consensus RatingReduce Company Overview Mesa Laboratories, Inc. (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes. The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications. Mesa Laboratories also offers calibration standards, software platforms and technical support services that enable clients to maintain accurate instrument performance and fulfill industry-specific quality assurance requirements. Since its founding in 1968, Mesa Laboratories has expanded through a combination of in-house research and development and strategic acquisitions to broaden its instrumentation offerings and geographic reach. The company maintains manufacturing and service facilities across North America, Europe and the Asia-Pacific region, leveraging a global distribution network to deliver products and support to customers in more than 100 countries.AI Generated. May Contain Errors. Read More Mesa Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks31st Percentile Overall ScoreMLAB MarketRank™: Mesa Laboratories scored higher than 31% of companies evaluated by MarketBeat, and ranked 849th out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingReduce Consensus RatingMesa Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating.Downside RiskMesa Laboratories has a consensus price target of $67.00, representing about 9.6% downside from its current price of $74.15.Amount of Analyst CoverageMesa Laboratories has only been the subject of 3 research reports in the past 90 days.Read more about Mesa Laboratories' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth9.00% Earnings GrowthEarnings for Mesa Laboratories are expected to grow by 9.00% in the coming year, from $8.00 to $8.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Mesa Laboratories is -529.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mesa Laboratories is -529.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMesa Laboratories has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Mesa Laboratories' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.05% of the outstanding shares of Mesa Laboratories have been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mesa Laboratories has recently decreased by 20.45%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldMesa Laboratories has a dividend yield of 0.94%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthMesa Laboratories does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 7.34% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.Read more about Mesa Laboratories' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted6.05% of the outstanding shares of Mesa Laboratories have been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mesa Laboratories has recently decreased by 20.45%, indicating that investor sentiment is improving significantly. News and Social Media2.1 / 5News Sentiment0.83 News SentimentMesa Laboratories has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Mesa Laboratories this week, compared to 3 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Mesa Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.90% of the stock of Mesa Laboratories is held by insiders.Percentage Held by Institutions90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Mesa Laboratories' insider trading history. Receive MLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLAB Stock News HeadlinesAnalyzing Mesa Laboratories (NASDAQ:MLAB) & Integer (NYSE:ITGR)October 7, 2025 | americanbankingnews.comMesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025October 3, 2025 | globenewswire.comOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.October 16 at 2:00 AM | Crypto 101 Media (Ad)Mesa Laboratories (NASDAQ:MLAB) shareholders are up 19% this past week, but still in the red over the last five yearsSeptember 21, 2025 | finance.yahoo.comMesa Laboratories Holds Annual Shareholder MeetingAugust 25, 2025 | tipranks.comIt Might Not Be A Great Idea To Buy Mesa Laboratories, Inc. (NASDAQ:MLAB) For Its Next DividendAugust 24, 2025 | finance.yahoo.comMesa Laboratories (NASDAQ:MLAB) Has Announced A Dividend Of $0.16August 20, 2025 | finance.yahoo.comMesa Laboratories, Inc.: Mesa Laboratories Executes Previously-Announced Strategic Financing PlanAugust 19, 2025 | finanznachrichten.deSee More Headlines MLAB Stock Analysis - Frequently Asked Questions How have MLAB shares performed this year? Mesa Laboratories' stock was trading at $131.87 at the beginning of the year. Since then, MLAB shares have decreased by 43.8% and is now trading at $74.15. How were Mesa Laboratories' earnings last quarter? Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its earnings results on Tuesday, February, 4th. The medical instruments supplier reported $2.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.41 by $0.66. The medical instruments supplier had revenue of $62.84 million for the quarter, compared to analysts' expectations of $58.83 million. Mesa Laboratories had a negative net margin of 0.26% and a positive trailing twelve-month return on equity of 24.49%. Who are Mesa Laboratories' major shareholders? Top institutional shareholders of Mesa Laboratories include Rice Hall James & Associates LLC (0.31%), CWM LLC (0.01%) and Farther Finance Advisors LLC (0.01%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, John Sakys, Shannon Hall and Brian David Archbold. View institutional ownership trends. How do I buy shares of Mesa Laboratories? Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Mesa Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings2/04/2025Record date for 9/15 Dividend8/29/2025Ex-Dividend for 9/15 Dividend8/29/2025Dividend Payable9/15/2025Today10/16/2025Next Earnings (Estimated)11/06/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryElectronic Equipment & Instruments Current SymbolNASDAQ:MLAB CIK724004 Webwww.mesalabs.com Phone(303) 987-8000Fax303-987-8989Employees680Year Founded1982Price Target and Rating Average Price Target for Mesa Laboratories$67.00 High Price Target$67.00 Low Price Target$67.00 Potential Upside/Downside-7.8%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.14) Trailing P/E RatioN/A Forward P/E Ratio9.08 P/E GrowthN/ANet Income-$1.97 million Net Margins-0.26% Pretax Margin3.74% Return on Equity24.49% Return on Assets9.03% Debt Debt-to-Equity Ratio0.46 Current Ratio0.66 Quick Ratio0.47 Sales & Book Value Annual Sales$242.35 million Price / Sales1.65 Cash Flow$12.46 per share Price / Cash Flow5.83 Book Value$29.42 per share Price / Book2.47Miscellaneous Outstanding Shares5,502,000Free Float5,232,000Market Cap$399.69 million OptionableNot Optionable Beta0.86 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:MLAB) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWall St’s “AI Godfather” breaks his silenceWhats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThis dark force is about to change everythingTwo Nobel Prize winners warn of this once-in-a-generation wealth shift…THE FINAL DISPLACEMENT An unstoppabl...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
